Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedAug 03, 2026
DataAggregated Company Financials
Companies6
- 7D6.6%
- 3M-17.5%
- 1Y-24.5%
- YTDn/a
Over the last 7 days, the Drug Retail industry has risen 6.6%, driven by gains from JD Health International of 6.5%. In the same time, Lung Fung Group Holdings was down 9.6%. In the past year, the industry is down 24%. As for the next few years, earnings are expected to grow by 15% per annum.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 03 Aug 2026 | HK$203.2b | HK$143.6b | HK$8.7b | 31.8x | 23.2x | 1.4x |
| Wed, 01 Jul 2026 | HK$172.7b | HK$142.8b | HK$8.7b | 28.1x | 19.9x | 1.2x |
| Fri, 29 May 2026 | HK$204.2b | HK$142.9b | HK$8.7b | 34.2x | 23.5x | 1.4x |
| Sun, 26 Apr 2026 | HK$249.7b | HK$140.3b | HK$8.6b | 44.3x | 29x | 1.8x |
| Tue, 24 Mar 2026 | HK$255.9b | HK$140.4b | HK$8.1b | 85.2x | 31.7x | 1.8x |
| Thu, 19 Feb 2026 | HK$331.0b | HK$129.4b | HK$6.9b | 45.7x | 47.8x | 2.6x |
| Sat, 17 Jan 2026 | HK$370.6b | HK$128.0b | HK$6.9b | 50.9x | 54.1x | 2.9x |
| Mon, 15 Dec 2025 | HK$313.8b | HK$126.2b | HK$6.8b | 40.5x | 46.4x | 2.5x |
| Wed, 12 Nov 2025 | HK$327.1b | HK$122.2b | HK$6.1b | 59.5x | 53.2x | 2.7x |
| Fri, 10 Oct 2025 | HK$354.0b | HK$122.3b | HK$6.1b | 65.7x | 57.6x | 2.9x |
| Sun, 07 Sep 2025 | HK$368.4b | HK$122.3b | HK$6.1b | 66.8x | 59.9x | 3x |
| Tue, 05 Aug 2025 | HK$274.6b | HK$115.4b | HK$4.5b | 50.5x | 60.9x | 2.4x |
| Thu, 03 Jul 2025 | HK$238.7b | HK$115.5b | HK$4.5b | 47.8x | 52.9x | 2.1x |
| Sat, 31 May 2025 | HK$225.6b | HK$115.0b | HK$4.5b | 46.7x | 50.2x | 2x |
| Mon, 28 Apr 2025 | HK$214.7b | HK$109.9b | HK$4.1b | 58.2x | 51.8x | 2x |
| Wed, 26 Mar 2025 | HK$210.6b | HK$110.6b | HK$4.2b | 61.5x | 50.5x | 1.9x |
| Fri, 21 Feb 2025 | HK$229.7b | HK$104.1b | HK$3.6b | 55.9x | 63.8x | 2.2x |
| Sun, 19 Jan 2025 | HK$154.8b | HK$103.3b | HK$3.6b | 37x | 43.3x | 1.5x |
| Tue, 17 Dec 2024 | HK$163.0b | HK$103.7b | HK$3.6b | 38.7x | 45.4x | 1.6x |
| Thu, 14 Nov 2024 | HK$176.0b | HK$103.4b | HK$3.3b | 50.7x | 53.6x | 1.7x |
| Sat, 12 Oct 2024 | HK$181.8b | HK$105.3b | HK$3.3b | 52.2x | 54.4x | 1.7x |
| Mon, 09 Sep 2024 | HK$137.2b | HK$105.4b | HK$3.3b | 37x | 41x | 1.3x |
| Wed, 07 Aug 2024 | HK$141.4b | HK$103.5b | HK$2.4b | 42.4x | 58.3x | 1.4x |
| Fri, 05 Jul 2024 | HK$139.4b | HK$101.8b | HK$2.4b | 42.3x | 58.4x | 1.4x |
| Sun, 02 Jun 2024 | HK$155.3b | HK$102.4b | HK$2.4b | 45.7x | 64.8x | 1.5x |
| Tue, 30 Apr 2024 | HK$155.3b | HK$103.7b | HK$2.3b | 46.5x | 66.7x | 1.5x |
| Thu, 28 Mar 2024 | HK$157.0b | HK$103.6b | HK$13.7m | 47.5x | 11440x | 1.5x |
| Sat, 24 Feb 2024 | HK$175.9b | HK$105.1b | -HK$1,455,720,716.63 | 58.2x | -120.8x | 1.7x |
| Mon, 22 Jan 2024 | HK$165.0b | HK$105.6b | -HK$1,463,400,225.00 | 52.8x | -112.7x | 1.6x |
| Wed, 20 Dec 2023 | HK$204.2b | HK$105.6b | -HK$1,462,974,668.00 | 63.5x | -139.6x | 1.9x |
| Fri, 17 Nov 2023 | HK$225.4b | HK$102.4b | -HK$1,745,066,992.00 | 90.9x | -129.2x | 2.2x |
| Sun, 15 Oct 2023 | HK$224.7b | HK$102.4b | -HK$1,675,089,400.00 | 104.7x | -134.2x | 2.2x |
| Tue, 12 Sep 2023 | HK$237.0b | HK$102.6b | -HK$1,678,727,589.00 | 84.6x | -141.1x | 2.3x |
| Thu, 10 Aug 2023 | HK$281.3b | HK$96.0b | -HK$4,163,368,048.00 | 130.6x | -67.6x | 2.9x |
Price to Earnings Ratio
-67.6x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 23.2x which is lower than its 3-year average PE of 100x.
- The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 14% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | 2.63% | |
| Consumer Staples | 5.90% | |
| Food and Staples Retail | 6.53% | |
| Drug Retail | 6.58% | |
| Food Retail | 8.09% | |
| Food Distributors | -1.42% | |
| Big Box Super Stores | -1.82% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6618 JD Health International | HK$39.38 | 4.2% +HK$5.1b | -21.1% | PE20.1x | |
| 241 Alibaba Health Information Technology | HK$3.60 | 5.4% +HK$3.0b | -26.8% | PE25.8x | |
| 1833 Ping An Healthcare and Technology | HK$7.67 | 1.9% +HK$297.7m | -35.0% | PE37x |